Clinical Trials Directory

Trials / Completed

CompletedNCT07133334

Evaluation and Comparison of the Benefits of Routine vs Shampoo Alone During 4 Weeks Treatment and 12 Weeks Remanence

Evaluation and Comparison of the Benefits of Routine vs Shampoo Alone During 4 Weeks of Treatment and 12 Weeks Remanence n Subjects With Moderate to Severe Dandruff

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Vichy Laboratoires · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to to evaluate and compare the efficacy of the routine "Shampoo + Conditioner " versus " Shampoo alone" immediately after application and after 1 week, 2 weeks, 3 weeks, 4 weeks (treatment phase) and 5 weeks, 8 weeks, 10 weeks and 12 weeks after applications stop (remanence phase) on subjects with moderate to severe dandruff. Participants will: Apply investigationnal products 3 time a week during 4 weeks and neutral or investigational products 3 time a week during 12 weeks Visit the center 9 times during the study for evaluations Keep a diary of their discomfort and the number of times they use the investigational products

Detailed description

Secondary objectives: * To evaluate and compare the Quality of Life (QoL) evolution of the routine " Shampoo and Conditioner " versus " Shampoo " alone, immediately after application and after 1, 2, 3, 4 weeks (treatment phase) and 5 weeks, 8 weeks, 10 weeks and 12 weeks after applications stop (remanence phase); * To assess and compare the cosmetic properties of routine " Shampoo and Conditioner " versus " Shampoo " alone, immediately after application and after 1, 2, 3 and 4 weeks of use (treatment phase); * To assess the tolerance of routine " Shampoo and Conditioner " versus " Shampoo " alone, during 4 weeks of use.

Conditions

Interventions

TypeNameDescription
OTHERSelenium disulfide1% SeS2
OTHERPiroctone olamine0.5% piroctone olamine

Timeline

Start date
2025-04-02
Primary completion
2025-08-18
Completion
2025-09-30
First posted
2025-08-21
Last updated
2026-03-04

Locations

1 site across 1 country: Mauritius

Source: ClinicalTrials.gov record NCT07133334. Inclusion in this directory is not an endorsement.